| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5646279 | Journal of Allergy and Clinical Immunology | 2017 | 46 Pages |
Abstract
In patients with recurrent nasal polyposis receiving topical corticosteroids who required surgery, mepolizumab treatment led to a greater reduction in the need for surgery and a greater improvement in symptoms than placebo.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Claus PhD, Ana R. PhD, Valerie J. MD, Glenis K. MD, Philippe MD, Shuaib MD, Stephen R. MD, Marjolein E. MD, Harsha H. PhD, Jane MSc, Daren PhD, Aoife C. PhD, Richard P. PhD, Wytske J. PhD,